Symptomatic Neurogenic Orthostatic Hypotension: Clinical Trials

1 trial for Symptomatic Neurogenic Orthostatic Hypotension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Symptomatic Neurogenic Orthostatic Hypotension: new trials by email Literature Review of Symptomatic Neurogenic Orthostatic Hypotension trials Research Report on Symptomatic Neurogenic Orthostatic Hypotension

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Droxidopa capsules, Placebo capsules - Symptomatic Neurogenic Orthostatic Hypotension
Phase 4CompletedH. Lundbeck A/S4532016-02-112023-08-23

Narrower conditions

Multiple System Atrophy (1)  ·  Parkinson Disease (1)  ·  Pure Autonomic Failure (1)  ·  dopamine beta hydroxylase deficiency (1)

Broader conditions

Autonomic Nervous System Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Parkinsonian Disorders (1)  ·  Primary Dysautonomias (1)  ·  Synucleinopathies (1)

Interventions

Droxidopa (1)

Sponsors

H. Lundbeck A/S (1)

Countries

United States (1)

Results publications

PMID 35107750